(TheNewswire)
MISSISSAUGA, Ontario – TheNewswire - March 29, 2021 – Sire Bioscience Inc.(CSE:SIRE) (OTC:BLLXF) (FSE:BR1B) (CNSX:SIRE.CN) (“SIRE” or the “Company”) announces that, pursuant to a consultingagreement (the “ Agreement ”) entered into with a consultant(the “ Consultant ”) and subject to the approval of the CNSX Markets Inc., itproposes to issue 59,524 common shares (the “ Shares ”) of theCompany at a deemed price of $0.42 per Share for past servicesprovided by the Consultant.
Pursuant to the Agreement, the Company agreed toremunerate the Consultant $25,000, exclusive of HST, per quarter,payable in Shares of the Company. The deemed value of the Shareswill be determined by the closing market price on the day proceedingthe issuance of the Shares. The issuance of 59,524 Shares representsthe first of four payments to the Consultant.
All Shares issued pursuant to the Agreement will besubject to a mandatory four month hold period from the dates ofissuances.
About Sire Bioscience
SIRE is headquartered in Mississauga, Ontario with itswholly owned subsidiary PLANTFUEL® based inDenver, Colorado. SIRE is managed by a groupof successful entrepreneurs who have extensive experience in the areasof consumer-packaged goods, manufacturing, logistics, anddistribution. SIRE is a CPG life science company focused on theplant-based foods and supplements industry.
For additional informationcontact:
Sire Bioscience Inc.
Website: sirebioscience.com
Socials: @sirebioscience
The securities referred to in thisnews release have not been, nor will they be, registered under theUnited States Securities Act of 1933, as amended, and may not beoffered or sold within the United States or to, or for the account orbenefit of, U.S. persons absent U.S. registration or an applicableexemption from the U.S. registration requirements.
This news release does not constitutean offer for sale of securities for sale, nor a solicitation foroffers to buy any securities. Any public offering of securities inthe United States must be made by means of a prospectus containingdetailed information about the company and management, as well asfinancial statements.
NOT FOR DISSEMINATION IN THE UNITEDSTATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOTCONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN
Copyright (c) 2021 TheNewswire - All rights reserved.